Issue 2/2025
Content (19 Articles)
A Real-World Approach to Trifarotene Treatment in Patients with Acne and Acne Sequelae Based on the Experience of the Italian Acne Board
- Open Access
- Acne
- Commentary
Maria Carmela Annunziata, Mauro Barbareschi, Vincenzo Bettoli, Federica Dall’Oglio, Giuseppe Micali, Giuseppe Monfrecola, Nevena Skroza, Matteo Tretti Clementoni, Stefano Veraldi
CDKN2A Mutation: A Patient’s and Physician’s Experience
- Open Access
- Melanoma
- Commentary
Yaelle Shaked, Alyssa Swearingen, Tracey N. Liebman
Application of Ultraviolet-Induced Fluorescence Trichoscopy (UVFT) in Hair and Scalp Diseases
- Open Access
- Alopecia
- Original Research
Kinga Kołcz, Adam Reich, Magdalena Żychowska
Quality of Life in Adults with Atopic Dermatitis in Relation to Disease Severity: Nationwide Data in Japan
- Open Access
- Atopic Dermatitis
- Original Research
Hiroyuki Murota, Takeshi Nakahara, Shinichi Noto, Miyuki Matsukawa, Hiroe Takeda, Rikiya Toda
Association Between Local Skin Reactions and Efficacy with 5-Fluorouracil 4% Cream in Actinic Keratosis: A Post-Hoc Analysis of Two Randomised Clinical Trials
- Open Access
- Actinic Keratosis
- Original Research
Markus V. Heppt, Kilian Trin, Anne-Cécile Mille, Mélanie Groc, Alain Delarue, Nathalie Bégeault
Real-Life Experience with Tildrakizumab in Plaque Psoriasis with Palmoplantar Involvement: A Multi-Center Retrospective Italian Study
- Open Access
- Vulgar Psoriasis
- Original Research
Federico Diotallevi, Maria Esposito, Maria Concetta Fargnoli, Pietro Quaglino, Luca Mastorino, Luca Stingeni, Katharina Hansel, Claudio Feliciani, Matteo Megna, Lucia Gallo, Agostina Legori, Giuseppe Argenziano, Anna Balato, Federico Bardazzi, Martina Burlando, Emanuele Cozzani, Luca Bianchi, Marco Galluzzo, Paolo Gisondi, Francesco Bellinato, Tommaso Bianchelli, Giovanni Marco D’Agostino, Giulia Matacchione, Anna Campanati
Effectiveness of Tralokinumab in Different Phenotypes of Atopic Dermatitis: A Real-World Study
- Open Access
- Atopic Dermatitis
- Original Research
Ersilia Tolino, Luca Ambrosio, Nicoletta Bernardini, Ilaria Proietti, Nevena Skroza, Concetta Potenza
Efficacy, Safety, and Cost-effectiveness of Zinc Oxide Nanoparticles in Whitfield’s Spirit Solution for Treating Superficial Fungal Foot Infections: A Randomized Controlled Trial
- Open Access
- Original Research
Charussri Leeyaphan, Primana Punnakitikashem, Bordeesuda Suiwongsa, Phojana Komesmuneeborirak, Piriyaporn Chongtrakool, Nattanichcha Kulthanachairojana, Pichaya Limphoka, Thrit Hutachoke, Phuwakorn Saengthong-aram, Pantaree Kobkurkul, Supisara Wongdama, Bawonpak Pongkittilar, Lalita Matthapan, Chatisa Panyawong, Waranyoo Prasong, Akkarapong Plengpanich, Natsuda Kunwong, Kamonlatth Rodponthukwaji, Sumanas Bunyaratavej
Switching from Dupilumab to Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of Efficacy After Treatment With Dupilumab in JADE DARE
- Open Access
- Dupilumab
- Original Research
Jonathan I. Silverberg, Eric L. Simpson, Andrew E. Pink, Stephan Weidinger, Gary Chan, Pinaki Biswas, Claire Clibborn, Erman Güler
Real-World Effectiveness of Risankizumab in Patients with Moderate-to-Severe Psoriasis: Interim Analysis from the VALUE Global Prospective Post-marketing Observational Study at 25 Months
- Open Access
- Vulgar Psoriasis
- Original Research
Diamant Thaçi, Mamitaro Ohtsuki, Julia-Tatjana Maul, Andrea Szegedi, Paula C. Luna, Charles W. Lynde, Ahmed M. Soliman, Hongwei Wang, Christian Kaufmann, Doug G. Ashley, Tshepiso Madihlaba, Simone Rubant, Kim A. Papp
Analysis of Predefined Safety Events Across Spesolimab Trials in Dermatological and Non-Dermatological Conditions
- Open Access
- Pustular Psoriasis
- Original Research
Kenneth B. Gordon, Yayoi Tada, Milan J. Anadkat, Siew Eng Choon, Boni Elewski, Jonathan N. Barker, Arash Mostaghimi, Kilian Eyerich, Ming Tang, Thomas Haeufel, Christian Thoma, Diamant Thaçi
Healthcare Resource Utilization and Economic Burden of Prurigo Nodularis in the United States
- Open Access
- Atopic Dermatitis
- Original Research
Shawn G. Kwatra, Ashis K. Das, Eunice Chang, Caleb Paydar, Donia Bahloul, Chao Chen, Ryan B. Thomas
Management of Systemic Anti-psoriatic Drugs in Psoriasis Patients with Concurrent Paraplegia or Tetraplegia: Insights From a 6-Year Multicenter, Retrospective Observational Study
- Open Access
- Vulgar Psoriasis
- Brief Report
Giovanni Damiani, Alessia Pacifico, Stefano Ricciardi, Valeria Corazza, David Trigos, Marco Fiore, Claudio Guarneri
Baricitinib Provides Significant Improvements in Quality of Life and Functioning in Adults with Moderate-to-Severe Atopic Dermatitis with Baseline Body Surface Area ≤ 40% and Severe Itch
- Open Access
- Baricitinib
- Brief Report
Matthias Augustin, Maddalena Napolitano, Rosa Izu-Belloso, C. Elise Kleyn, Silvia Sabatino, Susanne Grond, Joaquin R. Otero-Asman, Chunyuan Liu, Ziad Reguiai, Toshifumi Nomura
A Retrospective Study of Pediatric Allergic Contact Dermatitis from 2017–2022
- Open Access
- Allergic Contact Dermatitis
- Brief Report
Jessica N. Pixley, Christina Kontzias, Rachel E. Tao, Lauren Massey, Kimberly Mcpeeks, Katherine Neighbors, Radhika Srivastava, Steven R. Feldman, Craig Burkhart
Deucravacitinib: Adverse Events of Interest Across Phase 3 Plaque Psoriasis Trials
- Open Access
- Plaque Psoriasis
- Brief Report
Joseph F. Merola, Laura K. Ferris, Jeffrey M. Sobell, Howard Sofen, John Osborne, John Vaile, Ying-Ming Jou, Carolin Daamen, Julie Scotto, Thomas Scharnitz, Mark Lebwohl
Implementation Science to Improve the Diagnosis and Management of Hidradenitis Suppurativa: HELyx Study Design Overview
- Open Access
- Acne Inversa
- Study Protocol
John R. Ingram, Georgios Kokolakis, Barry M. McGrath, Marco Romanelli, Falk G. Bechara, Antonio Martorell, Mona Biermann, Yvonne Geissbühler, Benjamin M. Haeberle, Mahrukh Zahid, Michael Fritz, Erhard Quebe-Fehling, Craig Richardson, Pierre-André Becherel
Correction: Matching-Adjusted Indirect Comparison of the Efficacy at Week 32 of Tralokinumab and Dupilumab in the Treatment of Moderate-to-Severe Atopic Dermatitis
- Open Access
- Dupilumab
- Correction
Tiago Torres, Anne Sohrt Petersen, Ulla Ivens, Albert Bosch Vilaro, John Stinson, José Manuel Carrascosa
Correction: Efficacy and Safety of Risankizumab in Patients with Psoriasis Showing Suboptimal Response to Secukinumab or Ixekizumab: Results from a Phase 3b, Open-Label, Single-Arm (aIMM) Study
- Open Access
- Vulgar Psoriasis
- Correction
Richard B. Warren, Lev Pavlovsky, Antonio Costanzo, Michael Bukhalo, Neil J. Korman, Yu-Huei Huang, Georgios Kokolakis, Andreas Pinter, Nadia Ibrahim, Yanbing Zheng, Leonidas Drogaris, Vassilis Stakias, Ahmed M. Soliman, Simone Rubant, Diamant Thaçi
